Jump to content

  • Log in with Facebook Log in with Twitter Log in with Windows Live Log In with Google      Sign In   
  • Create Account

Submit your paper to J Biol Methods today!
Photo

EMBO|EMBL Symposium: Mechanisms of Neurodegeneration

animal models genetics biomarkers

  • Please log in to reply
No replies to this topic

#1 EMBL

EMBL

    Enthusiast

  • Active Members
  • PipPipPipPipPip
  • 33 posts
0
Neutral

Posted 13 May 2016 - 12:13 AM

14 June 2017 - 17 June 2017

 

This symposium will focus on the molecular basis of major neurodegenerative diseases such as Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis, with a strong emphasis on mechanism based drug development. The meeting will cover the various molecular mechanisms linked to these diseases, including RNA biology, nuclear transport, protein processing, protein aggregation and protein folding. The symposium will also address the genetic components underlying neurodegeneration and the involvement of innate immune responses, discuss disease biomarkers and therapeutic options, as well as using animal models for studying neurodegenerative disease.This symposium will focus on the molecular basis of major neurodegenerative diseases such as Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis, with a strong emphasis on mechanism based drug development. The meeting will cover the various molecular mechanisms linked to these diseases, including RNA biology, nuclear transport, protein processing, protein aggregation and protein folding. The symposium will also address the genetic components underlying neurodegeneration and the involvement of innate immune responses, discuss disease biomarkers and therapeutic options, as well as using animal models for studying neurodegenerative disease.

 

 

The aim of the meeting is to promote discussions and sharing of new findings among basic scientists, clinical researchers, and their counterparts from pharmaceutical industry, in order to advance our understanding of neurodegeneration and to further drug development in an area urgently requiring therapeutic progress. 

 

For more information please visit: http://www.embo-embl...7-04/index.html







Home - About - Terms of Service - Privacy - Contact Us

©1999-2013 Protocol Online, All rights reserved.